When Amedisys Inc. (Nasdaq: AMED) purchased Contessa Health, it touted the acquistion as a future-facing move that would allow the company to care for patients across the continuum. The company’s leaders knew it would be a near-term drag, and some analysts and home health insiders scratched their heads. Still, Amedisys reiterated the opportunity it saw […]
Contessa Health
Contessa Health’s leaders see palliative care as the true linchpin of their business and have plans to grow the segment in the near future. Though Amedisys Inc. (Nasdaq: AMED) purchased Contessa last year, it has allowed the company to operate independently, which has enabled Contessa leaders to maintain focus on their own growth trajectory, particularly […]
With all eyes focused on the home, it’s no exaggeration to say there were dozens of blockbuster in-home care acquisitions last year. But while all transactions directly impact the buyers and sellers, only a handful help shape the trajectory of an entire market. As I started to think about my own home health and home […]
The COVID-19 pandemic continued to dominate headlines in 2021, despite the collective desire for it to be gone by this past summer. But it didn’t stop massive dealmaking, which made M&A just as big of a story in home-based care as the virus. Thus, those two topics took up a lot of Home Health Care […]
During an earnings call on Nov. 3, Amedisys Inc. (Nasdaq: AMED) leaders defended the company’s acquisition of hospital-at-home enabler Contessa Health. They also teased “substantial” deals for the company coming down the pike. A week later, Contessa announced that it had partnered with Penn State Health, which has a footprint that spans across 29 counties […]
“Resistance to change is proportional to how much the future might be altered by any given act.” The quote, a line from American horror author Stephen King, perfectly describes the situation in which hospital-at-home programs find themselves. As of Nov. 11, 83 health systems and 187 hospitals in 34 states were participating in the Acute […]
Aveanna inks deal for Comfort Care Home Health Aveanna Healthcare (Nasdaq: AVAH) has agreed to acquire Comfort Care Home Health for $345 million, according to financial filings. The Atlanta-based Aveanna went public through a $100 million IPO earlier this year. While it filed an 8-K on Oct. 1 for the deal, a press release has […]
Earlier this year, palliative care advocates were hopeful that a formal benefit for community-based services would be coming soon. While that hasn’t happened yet, the clear momentum around a reimbursement pathway for community-based palliative care has prompted more home health agencies and other providers to launch programs of their own. That’s a trend likely to […]
Higher-Acuity Care, Rate Stability and New M&A Priorities: Key Takeaways from the Q2 Earnings Season
The home health industry is at a pivotal moment, with operators weighing exciting new opportunities while simultaneously working through emerging challenges related to the COVID-19 virus. Amedisys Inc. (Nasdaq: AMED), LHC Group Inc. (Nasdaq: LHCG), Aveanna Healthcare Holdings Inc. (Nasdaq: AVAH) and other publicly traded providers discussed many of the industry’s biggest developments during their […]
Amedisys Inc. (Nasdaq: AMED) executives are still coming down from the excitement around closing the company’s market-moving acquisition of Contessa Health, a home-based care innovator dedicated to shifting higher-acuity care into the home. But along with big future plans for Contessa and its legacy segments, the Baton Rouge, Louisiana-based aging-in-place giant also continues to face […]
Subscribe
Receive industry updates and breaking news from HHCN